CureVac Shelves Covid-19 Vaccine, Focuses on Next-Generation Shot

The initial rush of pandemic vaccine development appears to have ended with only a handful of clear winners. The field may be narrowing further still as dozens of countries now clamor for supplies of the Pfizer shot, drawn by its high level of efficacy and a lack of concerns over rare side effects.

Biden’s Soft Infrastructure Agenda May Not Boost Growth

The president has sold soft infrastructure such as in child care,...

How the Pandemic Has Changed the Way High-End Art Is Sold

Private sales at Sotheby’s and Christie’s took off, as live-auction revenues...

Facebook to Hire 10,000 Workers in EU to Build Up ‘Metaverse’

Facebook is planning to create 10,000 jobs in the European Union...

China Third-Quarter Economic Growth Slows Sharply to 4.9%

China’s economy grew 4.9% in the third quarter from a year...